Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India
Sk. Joshi et al., Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India, INFEC IMMUN, 68(1), 2000, pp. 141-150
Liver-stage antigen 1 (LSA-1) is a potential vaccine candidate against pree
rythrocytic stages of malaria. We report here the immunogenicity of linear
synthetic constructs delineated as T-H-cell determinants from the nonrepeat
regions of Plasmodiumfalciparum LSA-1 in murine models and human subjects
from areas where malaria is endemic in Rajasthan State, India. Seven peptid
e constructs (LS1.1 to LS1.7) corresponding to predicted T-cell sites from
both the N- and C-terminal regions and peptide LS1R from a repeat region of
PfLSA-1 were synthesized to analyze the cellular immune responses. These l
inear peptides were also tested for humoral responses in order to determine
if there were any overlapping II-cell epitopes in the predicted T-cell sit
es. Most peptides induced cellular responses in peptide-immunized BALB/c an
d C57BL/6 mice as measured by proliferation and cytokine analysis. Cross-re
active T-cell recognition of P. falciparam-based peptides in Plasmodium ber
ghei-immune animals was evaluated, but only one peptide, LS1.2 (amino acids
1742 to 1760) triggered T-cell proliferation and interleukin-2 and gamma i
nterferon secretion in P. berghei-immune splenocytes of BALB/c and C57BL/6
mice as well as in Thamnomys gazellae (natural host of P. berghei ANKA). In
an enzyme-linked immunosorbent assay with the peptides, only one peptide,
LS1.1, was recognized by anti-P. berghei liver-stage serum. Three peptides
(LS1.1, LS1.2, and LS1.3) of the eight peptides tested in this study were r
ecognized by a relatively large percentage of P. falciparum-exposed human s
ubjects; the reactivities ranged from similar to 45% for LS1.3 to similar t
o 60% for LS1.1 and LS1.2. Interestingly, all of the eight putative T-cell
determinants were also recognized by the sera collected from malaria patien
ts, although the response was variable in nature. These T-H- and B-cell epi
topes may be of potential value for preerythrocytic antigen-based malaria s
ubunit vaccine formulations.